Rapid hemostasis of arterial puncture sites with collagen in patients undergoing diagnostic and interventional cardiac catheterization

Clinical Cardiology
S Silber

Abstract

Despite the continuous reduction of sheath sizes in diagnostic and interventional cardiac catheterizations and the discontinuation of coumadin use after coronary stent implantation, a challenging role remains for hemostatic devices in the sealing femoral puncture sites. Since the introduction of the vascular hemostatic device (VHD) in 1991 and the hemostatic puncture closing device (HPCD) in 1992, numerous studies investigating these devices have been published. The deployment success rates reported in 2,292 patients for VHD is 97%, ranging from 88 to 100%. For HPCD, the mean deployment success rate resulting from 622 published patients leads to an identical result of 97%, ranging between 91 and 100%. For time to hemostasis, data have been analyzed according to the four different clinical situations, depending on level of anticoagulation (none or full) and the time of sheath removal (immediate or delayed). In randomized studies, when compared with the manual control groups, both devices revealed a statistically significant reduction in time to hemostasis: 12 to 16 minutes less for diagnostic catheterization and 14 to 30 minutes less for PTCA. As for minor local complications, no clinically relevant differences seem to exist. No...Continue Reading

References

Dec 1, 1992·Catheterization and Cardiovascular Diagnosis·R SchräderM Kaltenbach
Jun 1, 1990·Journal of the American College of Cardiology·M J KernT M Bashore
Dec 1, 1988·Journal of the American College of Cardiology·R M WymanD S Baim
May 1, 1981·The Journal of Trauma·M E Silverstein, M Chvapil
May 1, 1995·European Heart Journal·H J Geschwind
Jan 1, 1995·Catheterization and Cardiovascular Diagnosis·D B BogartM A Montgomery
Jan 1, 1995·Catheterization and Cardiovascular Diagnosis·S IsmailW D Spotnitz
Mar 1, 1994·Catheterization and Cardiovascular Diagnosis·U T AkerW G Kussmaul
Nov 1, 1993·Journal of the American College of Cardiology·P B Krause, L W Klein
Dec 1, 1993·Catheterization and Cardiovascular Diagnosis·J G WebbA A Dodek
Aug 15, 1993·The American Journal of Cardiology·H de SwartH J Wellens
Apr 1, 1996·Catheterization and Cardiovascular Diagnosis·W G KussmaulJ G Sandza
Apr 1, 1996·Catheterization and Cardiovascular Diagnosis·R G CarereA A Dodek
Nov 1, 1996·European Heart Journal·E Macieira-Coelho
May 8, 1992·Journal of Interventional Cardiology·J S GibbsU Sigwart
Feb 1, 1965·Annals of Surgery·E E PEACOCKP W BIGGERS

❮ Previous
Next ❯

Citations

Feb 1, 2000·Herz·G Gershony, T Jensen
Nov 26, 2009·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Stephen Wai-Luen LeeHon-Wah Chan
Apr 24, 1999·The American Journal of Cardiology·S SilberW Schramm
Apr 13, 2005·Otolaryngologic Clinics of North America·Stephen T Flock, Kevin S Marchitto
Jul 6, 2000·Journal of Vascular Surgery·W PipkinJ S Mondy Iii
Dec 2, 2008·European Journal of Radiology·L Q HonR Uberoi
Dec 2, 2008·Current Problems in Diagnostic Radiology·Lye-Quen HonRaman Uberoi
May 8, 2003·Pharmacoepidemiology and Drug Safety·Dale R TavrisCarlos Bell
Oct 14, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·J B HermillerT M Chou
May 21, 2009·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Rekhi VargheseDavid Lasorda
May 18, 2000·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·M R MooneyM Lowrie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.